Mostrando ítems 1-4 de 4
Lapatinibe: uso em mulheres com câncer de mama metastático: revisão sistemática
(Universidade Estadual Paulista (Unesp), 2015-11-26)
Introduction: The five years survival of women with metastatic breast cancer accounts less than 25%. HER2 is an epidermal growth factor; the overexpression of HER2 in the cancer cells decreases survival of these patients ...